These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 11943258)

  • 1. Trichomegaly following treatment with interferon alpha-2b.
    Hernández-Núñez A; Fernández-Herrera J; Buceta LR; García-Díez A
    Lancet; 2002 Mar; 359(9312):1107. PubMed ID: 11943258
    [No Abstract]   [Full Text] [Related]  

  • 2. Eyelash and eyebrow trichomegaly induced by interferon-alfa 2a.
    Goksugur N; Karabay O
    Clin Exp Dermatol; 2007 Sep; 32(5):583-4. PubMed ID: 17509059
    [No Abstract]   [Full Text] [Related]  

  • 3. Trichomegaly of the eyelashes following treatment with cetuximab.
    Bouché O; Brixi-Benmansour H; Bertin A; Perceau G; Lagarde S
    Ann Oncol; 2005 Oct; 16(10):1711-2. PubMed ID: 15972283
    [No Abstract]   [Full Text] [Related]  

  • 4. Cetuximab-associated elongation of the eyelashes: case report and review of eyelash trichomegaly secondary to epidermal growth factor receptor inhibitors.
    Cohen PR; Escudier SM; Kurzrock R
    Am J Clin Dermatol; 2011 Feb; 12(1):63-7. PubMed ID: 20726623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trichomegaly of the eyelashes following treatment with cetuximab.
    Vaccaro M; Pollicino A; Barbuzza O; Guarneri B
    Clin Exp Dermatol; 2009 Apr; 34(3):402-3. PubMed ID: 19120397
    [No Abstract]   [Full Text] [Related]  

  • 6. Erlotinib-induced trichomegaly in a male patient with pancreatic cancer.
    Saif MW; Gnanaraj J
    Cutan Ocul Toxicol; 2010 Mar; 29(1):62-6. PubMed ID: 19954400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal failure after treatment with interferon alpha 2b.
    Roeloffzen WW; Hospers GA; De Vries EG; Navis GJ
    Anticancer Res; 2002; 22(3):1929-31. PubMed ID: 12168896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delayed wound healing following treatment with low-dose interferon alfa-2b for cutaneous melanoma.
    Ammoury AF; El Sayed F; Bazex J
    Arch Dermatol; 2007 Oct; 143(10):1339-40. PubMed ID: 17938359
    [No Abstract]   [Full Text] [Related]  

  • 9. Severe pleuropericarditis and cardiomyopathy induced by high dose interferon alpha-2b.
    Benjamini O; Kimhi O; Lishner M
    Isr Med Assoc J; 2007 Jun; 9(6):486-7. PubMed ID: 17642403
    [No Abstract]   [Full Text] [Related]  

  • 10. Ocular surface toxicity associated with topical interferon alpha-2b.
    Aldave AJ; Nguyen A
    Br J Ophthalmol; 2007 Aug; 91(8):1087-8. PubMed ID: 17638822
    [No Abstract]   [Full Text] [Related]  

  • 11. Trichomegaly of the eyelashes after colorectal cancer treatment with the epidermal growth factor receptor inhibitor cetuximab.
    Bambury R; McCaffrey JA
    Clin Colorectal Cancer; 2009 Oct; 8(4):235. PubMed ID: 19822516
    [No Abstract]   [Full Text] [Related]  

  • 12. Severe loss of vision during adjuvant interferon alfa-2b treatment for malignant melanoma.
    Lohmann CP; Kroher G; Bogenrieder T; Spiegel D; Preuner J
    Lancet; 1999 Apr; 353(9161):1326. PubMed ID: 10218534
    [No Abstract]   [Full Text] [Related]  

  • 13. Early signs of liver failure after low-dose interferon alfa-2b for cutaneous melanoma.
    Ammoury A; El Sayed F; Farah C; Bazex J
    J Am Acad Dermatol; 2008 Mar; 58(3):532-3. PubMed ID: 18280369
    [No Abstract]   [Full Text] [Related]  

  • 14. Pegylated interferon-induced eyelid and eyebrow trichomegaly during chronic hepatitis C.
    Howaizi M
    J Gastroenterol Hepatol; 2005 Dec; 20(12):1945-6. PubMed ID: 16336462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interstitial pneumonitis in a patient with melanoma treated with the high dose interferon alpha 2b regimen.
    Siegelmann-Danieli N; Bardo M; Law A; Fisk D; Bernath A
    Isr Med Assoc J; 2004 Oct; 6(10):636-7. PubMed ID: 15473596
    [No Abstract]   [Full Text] [Related]  

  • 16. Livedo reticularis associated with interferon alpha therapy in two melanoma patients.
    Ruiz-Genao DP; García-F-Villalta MJ; Hernández-Núñez A; Ríos-Buceta L; Fernández-Herrera J; García-Díez A
    J Eur Acad Dermatol Venereol; 2005 Mar; 19(2):252-4. PubMed ID: 15752306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunoblastic lymphoma following hairy cell leukemia treated with interferon alpha-2a].
    Granier H; Carre D; Morand C; Richecoeur M; Combes P; Martin J; Abgrall J
    Ann Med Interne (Paris); 1996; 147(3):221-2. PubMed ID: 8796098
    [No Abstract]   [Full Text] [Related]  

  • 18. Progressive trichomegaly.
    Vano-Galvan S; Moreno-Martin P; Jaén P
    Neth J Med; 2009 Jan; 67(1):35-6. PubMed ID: 19155549
    [No Abstract]   [Full Text] [Related]  

  • 19. [Trichomegaly due to cetuximab].
    Bagazgoitia L; Aboín S; Beà S; Muñoz E
    Med Clin (Barc); 2009 Sep; 133(8):323. PubMed ID: 19540538
    [No Abstract]   [Full Text] [Related]  

  • 20. Trichomegaly and poliosis of the eyelashes during cetuximab treatment of metastatic colorectal cancer.
    Rodriguez NA; Ascaso FJ
    J Clin Oncol; 2011 Jun; 29(18):e532-3. PubMed ID: 21483009
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.